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Background: Chronic total occlusion (CTO) intervention is still challenging because of
the limited procedural success rate and higher recurrence. It is not clear whether the
complete revascularization will significantly impact on angiographic and clinical out-
comes of CTO patients (pts) with multivessel disease (MVD).
Methods: A total of 138 consecutive CTO pts with MVD were divided into two groups;
complete revascularization (CR, n82) and CTO alone revascularization (CTO Alone,
n54) groups. Six-month angiographic and twelve-month clinical outcomes were
compared between the two groups.
Results: The baseline clinical characteristics were balanced between the two groups
except higher incidence of hypertension (73.8 vs. 57.3 p0.035) and a lower incidence of
Prior PTCA (12.5 vs. 34.4 p0.001) in the CR group. The overall procedural success rate,
procedural characteristics and procedure related complications associated with CTO were
not different between the two groups. Angiographic outcomes at 6 months were not
different. There was a trend toward higher incidence of target lesion revascularization
(TLR)-major adverse cardiac events (MACE) in the CR group, predominatly due to
higher incidence of TLR and repeat PCI 24 months as compared with CTO alone group
(Table).
Conclusions: CR strategy in CTO pts with MVD failed to show the clinical benefit up
to 24 months as compared with CTO alone revascularization. This is a hypothesis
generating result and randomized study with larger study population will be necessary to
get final conclusion.
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Background: Introduction Femoral access (FEM) is usually employed in percutaneous
coronary intervention (PCI) for chronic total occlusions (CTO) because this is considered
to provide better catheter support, and allows the use of larger diameter guiding catheters.
Hypothesis We assessed the hypothesis that the use of radial access (RAD), which is
typically 6-Fr catheter compatible, is comparable to FEM with respect to procedural
success for CTO.
Methods: Methods The study included all consecutive patients undergoing PCI for CTO
at 3 tertiary PCI centres between January 2004 and December 2011. CTO lesions were
graded as easy (score of 0), intermediate (1), difficult (2), and “very difficult” (3),
according to the angiographic J-CTO score. A multivariable mixed effect logistic
regression for clustered data was used to assess the impact of RAD on PCI success after
adjustment for patient characteristics, lesion difficulty graded by angiographic score,
vessel site, procedural techniques.
Results: Results A total of 1249 patients, median age 63 yrs-old (55-72, 25th-75th
percentile) undergoing PCI for 1402 CTO were included. RAD was used in 848 (60.5%)
lesions. The use of 7-Fr (0.8% vs. 6.7%, p0.001) or 8-Fr (0% vs 4.15%, p 0.001)
guiding catheters was significantly lower in the RAD group than in the FEM group. The
prevalence of difficult lesions (J-CTO score 2) was lower in the RAD group than in the
FEM group (39.4% vs 48.4%, p0.001). The use of 7-Fr or 8-Fr guiding catheters was
higher in lesions with J-CTO score  2 than in those with J-CTO score (6.1% vs 2.1%,
p0.001). PCI success rate was slightly higher in the RAD group than in the FEM group
(72.6% vs. 68.4%), although this difference did not achieve the statistical significance
(p0.09). At multivariable logistic regression the use of RAD, as compared to FEM, was
not associated with procedural success (odds ratio 1.14, 95% confidence interval (CI)
0.88-1.48, p0.33).
Conclusions: Conclusions The use of RAD for PCI of CTO is feasible in the vast
majority of lesions and it is associated with a comparable success rate to that achieved
using FEM.
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Background: Little is known about procedural success rates and long-term clinical
outcomes of percutaneous coronary intervention (PCI) of chronic total occlusions (CTO)
in elderly patients (75 years).
Methods: Between 1998 and 2007, a total of 1791 pts with 1852 CTO underwent PCI
at three centers in the US, Italy and South Korea. Time-to-event analyses were performed
and differences evaluated between pts aged 75 vs. 75 years.
Results: A total of 213 patients (12%) were aged 75 years. The median [IQR] age in
this cohort was 78 [76, 81] years. Compared with patients  75 years, elderly patients
were more often female, more often had a history of chronic kidney disease and prior
CABG, and had a lower pre-procedural left ventricular ejection fraction.Procedural
success rates were similar in elderly patients compared with those 75 years (63.8% vs.
69.1%, p0.12). After successful CTO recanalization stents were implanted in 98% of
elderly patients (41% bare metal stents, 59% drug-eluting stents). Median follow-up was
1054 [530-1690] days . Five-year event rates are shown in table 1. In elderly patients who
underwent stent implantation after CTO PCI, the difference in TVR with BMS compared
to DES did not reach statistical significance (17.4% vs. 27.2%, p0.40) There were 2
cases of definite/probable stent thrombosis in both the BMS and the DES groups.
Table 1 Five-year clinical outcomes aftes successful vs failed CTO PCI in
patients aged >75 years and patients aged <75 years.
Age >75 years (n213, 11.9%) Age <75 years (n1578, 88.1%)
Successful
PCI
(n136,
63.8%)
Failed
PCI
(n77,
36.2%) P
Successful
PCI
(n1090,
69.1%)
Failed
PCI
(n488,
30.9%) P
MACE 25.8% 42.3% 0.02 11.2% 20.8% 0.01
Death 19.6% 24.6% 0.13 4.4% 6.1% 0.052
MI 11.5% 8.0% 0.87 5.1% 5.1% 0.89
CABG 0.0% 20.4% 0.01 3.6% 12.7% 0.01
Conclusions: The success rate for CTO PCI is similar in patients aged 75 years as for
those75 years. In elderly patients undergoing CTO PCI, successful revascularization is
associated with a reduction in MACE at 5-year follow-up, principally due to a reduced
need for CABG.
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Background: Catheter intervention is now one of popular medical procedures performed
widely over the world because of device improvement and several new technique
introductions. However, sometimes we face to technical problem when we deliver balloon
catheters in target lesion with heavy calcification or chronic total occlusion.
Methods: We applied an actuator driven by liner motor from ordinary electric razor
ES-LT20 (Panasonic Corporation, Osaka, Japan) for a new support system that decreases
friction resistance during catheter insertion to coronary arteries by generating adequate
vibration frequency. A phantom model of coronary intervention was assembled using test
vessels, guide wires and balloon catheters to evaluate the effects of the new support
system. We compared peak force, or friction resistance for catheter insertion with the new
support system to that without it by a digital force gauge, DPX5-T (IMADA Corporation,
Aichi, Japan).
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Results: Mean friction resistance (N) was significantly decreased with the new support
system (0.840.28 vs. 1.260.31, n18, p0.01). Any unfavorable phenomenon such
as device fracture was not observed during the support system use.
Conclusions: The new intervention support system could reduce friction resistance
during device insertion. Therefore, the system has potential ability to contribute to make
complex coronary intervention procedures such as those to heavily calcified lesions or
chronic total occlusions easier.
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Background: Introduction of drug-eluting stents (DES), which have been demonstrated
to cause less restenosis than bare-metal stents (BMS) in specific patient and lesion subsets,
has raised hopes of improving long-term vessel patency after chronic total occlusion
(CTO) recanalization. However, limited evidence of the benefit and safety of DES use in
CTO is available. We aim to analyze the short and long term outcomes of patients with
CTO treated with the latest generation drug eluting stent (DES) by pulling data from
NOBORI 2 and eNOBORI registries.
Methods: NOBORI2 and eNOBORI are two large, prospective, single-arm, multi-center,
registries that enrolled 3067 and 7750 patients respectively, out of which 97 and 302 had
treated CTO. All adverse events were adjudicated by an independent clinical event
committee in NOBORI 2, while adjudication in eNOBORI (including stent thrombosis)
is ongoing. The primary endpoint was Target Lesion Failure (TLF), a composite of
cardiac death (CD), target vessel related myocardial infarction (MI) and target lesion
revascularization (TLR).
Results: CTO patients were 60y old, 83% males, 50% with prior MI, 28% prior PCI
and 5% previous cardiac surgery. Multiple vessels were treated in 33% of patients
(2.201.43lesions per patient). The lesions were complex (82% B2/C type), ostial (17%),
calcified (43%), contained thrombus (2%) and 7% required bifurcation treatment. Pre- and
post-dilatation were performed in 86% and 34% of lesions respectively. At 1-month, there
were no deaths nor TLR, while there were 3 MI (1.2%) and one TVR (0.4%). The TLF
rate was 1.2%. In the cohort of patients followed at 3-year, 3 patients suffered a cardiac
death (3.1%), 1 had an MI (1.0%), 3 underwent TLR (3.1%) and TLF rate was 6.2%. A
total of 87% of the patients were angina free. No stent thrombosis occurred up to 3 years.
Conclusions: Treatment of CTO with Nobori DES showed favourable short- and
long-term outcomes. Low rates of procedural complications, short and long term adverse
events and the absence of stent thrombosis up to 3 years, despite the multiple overlapping
stents suggest that this stent is valuable treatment option for patients with CTO disease
considered as candidates for PCI.
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Background: To evaluate ischemia with FFR and LV function response to the
myocardium supplied by a CTO in pts with LV systolic dysfunction (LV EF 0.50).
Methods: Pts referred for angiogram for angina on optimal medical therapy and LVEF
0.50 underwent FFR evaluation of CTO (after partial recanalization with a small 1.5
mm balloon) and underwent PCI of CTO.
Results: Ten CTO and 10 matched non-CTO pts with severe stenosis 70% were
studied. Baseline characteristics were similar: age(60.9 	 8.9yrs), sex(males90%),
HTN(90%), diabetes (45%), hyperlipidemia(80%), CRI(30%), bypass surgery(25%), h/o
MI(50%) and Q waves on ECG(35%). LVEF at baseline was 35.710.6% in the CTO
and 42.37.9 in the non-CTO pts, (p 0.24). Pre-PCI FFR were 0.460.17 in the CTO
and 0.420.16 in the non-CTO groups (p 0.83) and; post-PCI FFR was similar
(0.880.09, CTO group and 0.900.05 non-CTO group, p0.57). At a mean f/u of 1.4
yrs, LV EF was significantly improved to 45.39.5% in the CTO group vs 35.710.6%
at baseline (p0.01), while there was a non-significant LV EF improvement in the
non-CTO group (45.49.8% vs 42.37.9%, p0.18) as shown in figure.
Conclusions: In pts with LV systolic dysfunction there is demonstrable ischemia
(FFR0.80) in the CTO territory, that is relieved after CTO PCI (FFR 0.80) with an
improvement in the LV systolic function.
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Background: The “hybrid approach” to chronic total occlusion (CTO) interventions
advocates early and frequent change of the utilized strategy to maximize efficiency.
Methods: We prospectively recorded detailed procedural information (strategy change
with corresponding procedural and fluoroscopy time and patient radiation exposure in 61
consecutive patients undergoing CTO intervention between July 2011 and May 2012.
Results: Fifty-five of 61 patients had successful CTO intervention with an overall
procedural success rate of 90.2%. Mean age was 65 7 years, all patients were men and
32% had prior coronary artery bypass graft surgery. The primary approach was retrograde
for 7 patients (11.5%) and antegrade for 54 patients (88.5%), of whom 21 patients (34.5%)
underwent retrograde intervention after failed antegrade approach (Table). Thirty-three
patients (54%) had no approach change, but 28/61 patients (46%) required 3.81.4
approach changes (range 2 -7) (Figure). The mean procedure time, fluoroscopy time,
radiation exposure and catheters and wires used are summarized in the Table.
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